Study shows age doesn't affect survival outcomes in patients with MDS who receive a HCT

(Padilla Speer Beardsley) Prospective study, presented at the 57th Annual Meeting of the American Society of Hematology, shows age doesn't affect survival outcomes in patients with myelodysplastic syndrome (MDS) who receive a hematopoietic cell transplant.